This brand name is authorized in Estonia, Lithuania, Tunisia
The drug LUSOPRESS contains one active pharmaceutical ingredient (API):
|
1
Nitrendipine
UNII 9B627AW319 - NITRENDIPINE
|
|
Nitrendipine is a dihydropyridine calcium channel blocker. It is used in the treatment of primary hypertension to decrease blood pressure. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C08CA08 | Nitrendipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1014545 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1002165, 1085615 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 8313021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
